Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Mobile App to Support Mood, Daily Routines and Medication Adherence in Adults With Severe Mental Illness
Sponsor: Alexandria University
Summary
The goal of this clinical trial is to learn whether MoodSync, a mobile application for patients and their family caregivers, improves mood stability, medication adherence, daily functioning and early detection of relapse warning signs in adults with severe mental illness in Bahrain. The main question it aims to answer is: Does MoodSync plus standard care improve manic symptoms, medication adherence, practical and social functioning, and early warning signs more than standard care alone? Participants will be randomly assigned to MoodSync plus standard care or standard care alone. MoodSync participants will use the patient app for 12 weeks for daily mood check-ins, sleep and activity tracking with a wearable device, medication reminders, daily-routine (social rhythm) support and early warning-sign reporting. A nominated family caregiver may use the linked caregiver app. All participants continue standard care and complete questionnaires before and after the intervention period. Research hypothesis: \* Patients who use MoodSync will show greater improvement in mood symptoms, medication adherence, practical and social functioning, and relapse-related outcomes than patients receiving standard care alone.
Official title: Effectiveness of MoodSync: A Just-in-Time Dual Mobile Application for Mood Monitoring, Social Rhythm Regulation, Medication Adherence, and Relapse Prevention Among Patients With Severe Mental Illness: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-11
Completion Date
2027-11
Last Updated
2026-10-16
Healthy Volunteers
No
Conditions
Interventions
MoodSync
A just-in-time dual mobile application (patient and family-caregiver versions) for daily mood monitoring, sleep and activity tracking via a wearable device, medication-adherence reminders, social rhythm regulation and early warning-sign reporting, used for 12 weeks. A nominated family caregiver may use the caregiver app with the patient's consent. High-risk alerts follow a predefined clinical safety protocol with referral to the responsible healthcare provider. The app does not replace clinical care.
Standard care
Participants continue routine psychiatric care, including clinic follow-up and prescribed medication, and complete the same assessments at baseline and post-test.
Locations (1)
Psychiatric Hospital, Government Hospitals
Manama, Bahrain